Skip to content

Plantago major L. in Erosive gastroduodenitis

Comparison of Plantago major seed with placebo on GI symptoms in patients with erosive gastroduodenitis

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190722044307N1
Enrollment
64
Registered
2019-09-07
Start date
2019-08-23
Completion date
Unknown
Last updated
2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Erosive gastroduodenitis. Gastroduodenitis, unspecified

Interventions

Intervention 1: Intervention group: Patients receive capsules of Plantago major seed (prepared in the Faculty of Traditional Medicine of Iran University of Medical Sciences) twice a day, each time re

Sponsors

Islamic Azad University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Erosive gastroduodenitis in endoscopy Negative Helicobacter pylori Test Written informed consent

Exclusion criteria

Exclusion criteria: pregnancy and lactation cardiovascular disease epilepsy anticoagulant medications use of a research drug in the past 30 day any factor to reduce patient compliance and tolerance, such as alcohol and drug abuse The existence of a severe illness that make performing endoscopy for them dangerous severe bleeding Coagulation Disorders Zollinger Ellison syndrome lung disease Malignancy

Design outcomes

Primary

MeasureTime frame
Severity of gastrointestinal symptoms. Timepoint: At the beginning of the study (before the intervention) and at the end of the study (28 days after the intervention). Method of measurement: A questionnaire derived from ROME III and Visual Analogue Scale questionnaire.;Frequency of symptoms in the week. Timepoint: At the beginning of the study (before the intervention) and at the end of the study (28 days after the intervention). Method of measurement: A questionnaire derived from ROME III.

Secondary

MeasureTime frame
Treatment Adverse reaction. Timepoint: End of the study. Method of measurement: Ask from patient.;Treatment satisfaction. Timepoint: End of the study. Method of measurement: Questionnair.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Fadaei

Islamic Azad University

f.fadaei.374@gmail.com_

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026